Re: Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer

被引：14
|
作者：
Drake, Charles G. [1 ]
机构：
[1] Johns Hopkins Univ, Dept Oncol, Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2012年 / 104卷 / 18期
关键词：
HOMEOSTATIC PROLIFERATION; CELLS; REJECTION; MELANOMA;
D O I：
10.1093/jnci/djs340
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1422 / 1422
页数：1
相关论文
共 50 条
  • [1] Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapy
    Bilen, Mehmet Asim
    Hess, Kenneth R.
    Subudhi, Sumit K.
    Aparicio, Ana
    Kim, Jeri
    Zurita-Saavedra, Amado J.
    Araujo, John C.
    Corn, Paul G.
    Stover, Jessica
    Lin, Sue-Hwa
    Logothetis, Christopher J.
    Tu, Shi-Ming
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (03) : 583 - 589
  • [2] Analysis of Circulating Immune Biomarkers by Race in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Sipuleucel-T
    Hawley, Jessica E.
    Pan, Samuel
    Kandadi, Harini
    Chaimowitz, Matthew G.
    Sheikh, Nadeem
    Drake, Charles G.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (02): : 314 - 317
  • [3] An overview of sipuleucel-T Autologous cellular immunotherapy for prostate cancer
    Wesley, Johnna D.
    Whitmore, James
    Trager, James
    Sheikh, Nadeem
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (04) : 520 - 527
  • [4] Cancer Immunotherapy: Sipuleucel-T and Beyond
    Hammerstrom, Aimee E.
    Cauley, Diana H.
    Atkinson, Bradley J.
    Sharma, Padmanee
    PHARMACOTHERAPY, 2011, 31 (08): : 813 - 828
  • [5] Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer
    Sinha, Meenal
    Zhang, Li
    Subudhi, Sumit
    Chen, Brandon
    Marquez, Jaqueline
    Liu, Eric V.
    Allaire, Kate
    Cheung, Alexander
    Ng, Sharon
    Nguyen, Christopher
    Friedlander, Terence W.
    Aggarwal, Rahul
    Spitzer, Matthew
    Allison, James P.
    Small, Eric J.
    Sharma, Padmanee
    Fong, Lawrence
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (05)
  • [6] IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Pachynski, Russell K.
    Morishima, Chihiro
    Szmulewitz, Russell
    Harshman, Lauren
    Appleman, Leonard
    Monk, Paul
    Bitting, Rhonda L.
    Kucuk, Omer
    Millard, Frederick
    Seigne, John D.
    Fling, Steven P.
    Maecker, Holden T.
    Duault, Caroline
    Ramchurren, Nirasha
    Hess, Bruce
    D'Amico, Leonard
    Lacroix, Andreanne
    Kaiser, Judith C.
    Morre, Michel
    Gregoire, Anne
    Cheever, Martin
    Yu, Evan Y.
    Fong, Lawrence
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (08)
  • [7] Sipuleucel-T for the Treatment of Advanced Prostate Cancer
    Frohlich, Mark W.
    SEMINARS IN ONCOLOGY, 2012, 39 (03) : 245 - 252
  • [8] Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association with Overall Survival
    Antonarakis, Emmanuel S.
    Small, Eric J.
    Petrylak, Daniel P.
    Quinn, David I.
    Kibel, Adam S.
    Chang, Nancy N.
    Dearstyne, Erica
    Harmon, Matt
    Campogan, Dwayne
    Haynes, Heather
    Tuyen Vu
    Sheikh, Nadeem A.
    Drake, Charles G.
    CLINICAL CANCER RESEARCH, 2018, 24 (19) : 4662 - 4671
  • [9] Immunotherapy for castration-resistant prostate cancer: has its time arrived?
    Slovin, Susan F.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (05) : 481 - 487
  • [10] Cabazitaxel in metastatic castration-resistant prostate cancer
    Yap, Timothy A.
    Pezaro, Carmel J.
    de Bono, Johann S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (09) : 1129 - 1136
12345